Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution-Non Commercial 3.0 Unported Licence

Cyclometalated Ir(III) complexes bridged by µ-OH and µ-3,5-bis(4-methoxyphenyl)-pyrazole ligands

Mausami a, Harshita Trivedia, Ranjan Patrab, Ravi Prakash Beherec, Biplab Kuilac, Sandeep Kumar Singh Patela, Mrituanjay D. Pandeyc, Biswajit Maitic and Bani Mahanti*a
aDepartment of Chemistry, Mahila Mahavidyalaya, Banaras Hindu University, Varanasi-221005, India. E-mail: bani@bhu.ac.in
bAmity Institute of Click Chemistry Research and Studies, Amity University, Noida, Uttar Pradesh, India
cDepartment of Chemistry, Institute of Science, Banaras Hindu University, Varanasi-221005, India

Received 1st February 2026 , Accepted 4th March 2026

First published on 10th March 2026


Abstract

Recent advances of cyclometalated Ir(III) complexes are due to their varied structural features and rich photophysical properties. Having this in mind, in the present investigation neutral, cyclometalated heterobridged Ir(III) dimers [(ppy)2Ir(µ-OH){µ-(PhOMe)2Pz}Ir(ppy)2] (1) and [(tpy)2Ir(µ-OH){µ-(PhOMe)2Pz}Ir(tpy)2] (2) (ppyH = 2-phenylpyridine; tpyH = 2-(p-tolyl)pyridine; (PhOMe)2PzH = 3,5-bis(4-methoxyphenyl)-pyrazole) are synthesized and characterized by various analytical techniques such as NMR, ESI-MS, UV-Vis, emission and cyclic voltammetric studies. Complex 1, has been also characterized by single crystal X-ray diffraction analysis. Both complexes are found to be emissive in aerated dichloromethane solution with emission maxima centered at around 550 nm for complex 1 and 546 nm for complex 2. Furthermore, density functional theory (DFT) and time-dependent density functional theory (TDDFT) calculations have been carried out on both complexes 1 and 2 to provide insights into their photophysical characteristics. The observed photophysical properties align well with the DFT and TDDFT results. Our electrochemical investigations demonstrate the stability of the complexes and also the fact that the bridging ligands play an important role in facilitating metal–metal communication within the dimers. In our important findings, we observe a unique interplay of ligand roles where modifying the ancillary ligand does not alter the photophysical properties of the resultant Ir(III) complexes, but are essential for the structural integrity and stability of the complexes. The pyrazole ligand used in the study, 3,5-bis(4-methoxyphenyl)-pyrazole, facilitates the assembly of robust dimeric structures, and the –OH ligand helps shift the spectral properties towards the red end of the spectrum. This study demonstrates that steric modulation can be used to significantly improve the synthesis and isolation of dinuclear Ir(III) complexes without relying on changes in electronic structure. This study provides a clear contrast to prior electronically driven approaches and establishes steric design as a strategy for the rational construction of dimeric cyclometalated Ir(III) complexes. Our results also underscore the significant impact of the bridging ligand on the electronic structure and spectroscopic properties of the cyclometalated Ir(III) complexes, potentially augmenting our understanding of the structure–property variations of such compounds and paving the way for their potential applications.


Introduction

Cyclometalated Ir(III) complexes have been the focus of increasing interest in recent years because of their remarkable photophysical properties, attracting sustained interest from research groups worldwide.1–8 This class of complexes serve as efficient phosphorescence emitters, featuring a luminescence efficiency four times greater than conventional fluorescence-based emitters (in principle).9–13 This enhanced performance arises from their ability to harvest both singlet and triplet excitons,9 theoretically achieving 100% quantum yield (Φp).10–14 The quantum yields vary widely, from less than 1% up to 100%. For example, the complex fac-tris(2-phenylpyridine) iridium(III) exhibits a quantum yield of 0.97 in dilute 2-MeTHF at room temperature.15 Experimental yields are often less than 100% because of non-radiative decay, quenching by oxygen, aggregation, thermal population of non-emissive states etc.16 The remarkable photophysical attributes of these complexes are due to spin–orbit coupling (SOC) induced by the heavy metal center of Ir(III), consequently facilitating an accelerated rate of intersystem crossing (ISC) between singlet and triplet excited states.17–21

A wide range of experimental and computational studies have examined cyclometalated Ir(III) complexes and identified important rules for changing emission colour by modifying the ligands.22–28 Although the use of electron-donating or withdrawing substituents for tuning phosphorescence has been well-established,29 there is still a significant drive to develop phosphors whose emission properties can be more readily tailored by modifying the electronic properties of both cyclometalating and ancillary ligands.30–32

Substituted pyrazole derivatives have played an important role in the assembly of phosphorescent Ir(III) complexes and other transition metals due to their ability to display versatile and adaptable coordination modes.33–36 Previously, Chandrasekhar et al. have reported heterobridged cyclometalated Ir(III) dimers (pyrazolate- and hydroxide-bridged) and investigated their photophysical and electrochemical properties. The complexes were found to be emissive, with the emission maxima being red-shifted compared to mononuclear analogues containing substituted pyrazole ancillary ligands. The hydroxy group as a bridging ligand also helped in effectively mediating the metal–metal communications in these systems.37 Liao et al. reported iridium(III) dimers containing bridging pyrazolate ligands. The complexes were found to be volatile and suitable for the fabrication of OLEDs.38 Building on these findings, we have introduced methoxy substitution (–OMe) into the ancillary 3,5-diphenyl pyrazole ligand backbone to examine its effect on the geometry and luminescence of the resulting complexes. Methoxy groups are known to function as an electron-withdrawing substituent by inductive effect and as an electron-donating substituent by mesomeric effect.39,40 Incorporation of methoxy (–OMe) groups into the 3,5-diphenyl pyrazole backbone is expected to introduce substantial steric bulk at the periphery of the complex. Consequently, such steric modulation is anticipated to promote the controlled and selective assembly of well-defined dinuclear species, while enhancing their stability and enabling their efficient isolation. We further anticipated that modulation of the steric bulk of the ligand would afford dimeric N, N-bridged complexes while limiting the formation of monomers and product mixtures, as was observed when 3,5-phenyl methyl pyrazole was employed as an ancillary ligand.37

Kamrul Hasan et al. have previously reported on tuning the emission towards the red in cationic Ir(III) complexes through methoxy substitution of the cyclometalating ligand.41 Davies et al. have reported tuning of emission wavelength and redox properties by varying substituents, including the methoxy group in 3-substituted 1-phenylpyrazoles, where the pyrazole ligand has been employed as a cyclometalating ligand.42 However, to the best of our knowledge, an investigation into methoxy group substitution in the ancillary diphenyl pyrazole ligand backbone has not been undertaken until now. Previous studies on dinuclear cyclometalated Ir(III) complexes have mainly focused on electronic tuning by modifying cyclometalating or ancillary ligands to adjust emission color or excited state behavior.43,44 While this strategy has proven effective for adjusting photophysical properties, it has comparatively little impact on the practical aspects of dinuclear complex formation, particularly with respect to isolation of discrete bimetallic species. In some cases, low yields, or difficulties in purification have hindered systematic exploration of dinuclear species.4 Bulky substituents on ancillary ligands are known to improve photophysical properties in cyclometalated Ir(III) complexes by affecting steric environments, showing the utility of steric design strategies.45 We propose that judicious steric modification of ligands at positions remote from the Ir(III) coordination core could provide an independent and underexplored strategy to control the formation of dinuclear cyclometalated Ir(III) complexes.

In this study, we present the synthesis, characterization, and detailed photophysical and electrochemical investigation of cyclometalated Ir(III) dimers featuring two different bridging ligands, [(ppy)2Ir(µ-OH){µ-(PhOMe)2Pz}Ir(ppy)2] (1) and [(tpy)2Ir(µ-OH){µ-(PhOMe)2Pz}Ir(tpy)2] (2), where ppyH = 2-phenylpyridine, tpyH = 2-(p-tolyl)pyridine, and (PhOMe)2PzH = 3,5-bis(4-methoxyphenyl)pyrazole. DFT and TDDFT calculations were carried out to further elucidate the photophysical behaviour of these complexes. One of our key findings in this work is that the introduction of methoxy (–OMe) groups into the 3,5-diphenyl pyrazole backbone leads to an increase in steric bulk at positions far from the metal coordination site. This change strongly affects how the dinuclear complexes form. The added steric hindrance makes the dimeric complexes easier to isolate, and directs the reaction toward the formation of a single, well-defined dimer rather than a mixture of products. Overall, our findings deepen the understanding of structure–property relationships and photophysical behaviour in cyclometalated Ir(III) systems and provide useful guidance for the rational design of iridium based phosphorescent materials.

Results and discussion

Synthesis and characterization

The heteroleptic Ir(III) dimers [(ppy)2Ir(µ-OH){µ-(PhOMe)2Pz}Ir(ppy)2] (1), [(tpy)2Ir(µ-OH){µ-(PhOMe)2Pz}Ir(tpy)2] (2) were isolated as orange solids by following the general two-step synthetic protocol. The first step involves the synthesis of the organometallic, cyclometalated chloro-bridged iridium(III) dimer precursor complexes, which are [(ppy)2Ir(µ-Cl)]2 and [(tpy)2Ir(µ-Cl)]2, respectively. The Nonoyama protocol was followed for the synthesis of the aforementioned precursors.46 The ancillary ligand (PhOMe)2PzH = 3,5-bis(4-methoxyphenyl)-pyrazole) was synthesized by condensation of 1,3-bis(4-methoxyphenyl)propane-1,3-dione with hydrazine hydrate in ethanol as solvent.47 In the second step, the iridium(III) dimers underwent a bridge splitting reaction on reaction with sodium methoxide, followed by 3,5-bis(4-methoxyphenyl)-pyrazole in dichloromethane solvent, affording the desired asymmetrically bridged cyclometalated Ir(III) dimers [(ppy)2Ir(µ-OH){µ-(PhOMe)2Pz}Ir(ppy)2] (1) and [(tpy)2Ir(µ-OH){µ-(PhOMe)2Pz}Ir(tpy)2] (2) with satisfactory yields (Scheme 1).
image file: d6ra00878j-s1.tif
Scheme 1 Synthesis of complexes 12.

Single crystals of 1 suitable for X-ray analysis were obtained by slow evaporation in dichloromethane solution, with a few drops of methanol added for layering at room temperature. The ORTEP diagram for the cyclometalated heterobridged Ir(III) dinuclear complex 1, which crystallized in the triclinic system with space group P[1 with combining overline], is shown in Fig. 1. Crystallographic data are presented in Table 1, while some selected bond lengths and bond angles are listed in Table 2. The geometry around Ir(III) metal atom in each monomeric unit is distorted octahedral, with the cyclometalating ligand arranged in a trans N,N and cis C–C configuration. The 3,5-bis(4-methoxyphenyl)-pyrazole ancillary ligand coordinates in µ-η11 fashion. The coordination of the two iridium centers with the bridging ligands (substituted pyrazolate and hydroxide) leads to the formation of a puckered five-membered [Ir2N2O] ring. The puckered conformation of the five-membered ring [Ir2N2O] is reflected in the Ir–O–Ir bond angle (124.6°), which is considerably larger than the bond angles O1–Ir1–N5 (81.0°) and O1–Ir2–N6 (81.4°) in the ring. The Ir–N bond lengths of cyclometalating ligand (1.997–2.064 Å) are slightly shorter compared to the Ir–N distance (2.187–2.201 Å) of the bridging pyrazolate ligand, likely due to the strong trans influence cyclometalating ligand's C atom. The Ir–C, Ir–O and non-bonding Ir⋯Ir bond lengths are 1.993–2.019 Å, 2.143–2.147 Å and 3.798 Å, respectively, which fall within the typical ranges for similar systems. The trans N–Ir–N and Ir–O–Ir bond angles are approximately 171.3°–172.3° and 124.6°, respectively, and are consistent with values reported in previous studies.37


image file: d6ra00878j-f1.tif
Fig. 1 ORTEP diagram of complex 1 with thermal ellipsoids at the 20% probability limit.
Table 1 Crystallographic data of complex 1
Empirical formula C61H47Ir2N6O3
Formula weight 1400.93
Temperature/K 293(2)
Crystal system Triclinic
Space group P[1 with combining overline]
a 11.9421(2)
b 15.4721(2)
c 15.7074(2)
α 86.0060(10)
β 89.7850(10)
γ 70.5140(10)
Volume/Å3 2728.78(7)
Z 2
ρcalc./g cm−3 1.705
µ/mm−1 10.228
F(000) 1372.0
Crystal size/mm3 0.28 × 0.26 × 0.2
Radiation Cu Kα (λ = 1.54184)
2Θ range for data collection/° 5.642–136.2
Index ranges −14 ≤ h ≤ 14, −18 ≤ k ≤ 18, −14 ≤ l ≤ 18
Reflections collected 17[thin space (1/6-em)]624
Independent reflections 17[thin space (1/6-em)]624 [Rint = 2.19, Rsigma = 0.0205]
Data/restraints/parameters 17[thin space (1/6-em)]624/1/653
Goodness-of-fit on F2 1.076
Final R indexes [I ≥ 2σ (I)] R1 = 0.0615, wR2 = 0.1778
Final R indexes [all data] R1 = 0.0660, wR2 = 0.1840
Largest diff. peak/hole/e Å−3 4.27/−1.25


Table 2 Selected bond lengths (Å) and angles (°) of complex 1
Bond length (Å)
Ir(1)–O(1) 2.147(6)
Ir(1)–N(5) 2.201(6)
Ir(1)–C(11) 2.011(9)
Ir(1)–C(12) 1.993(9)
N(2)–Ir(1)–N(1) (trans bond length) 2.050(6)⋯2.064(6)
Ir(2)–O(1) 2.143(6)
Ir(2)–N(6) 2.187(6)
Ir(2)–C(33) 2.007(9)
Ir(2)–C(44) 2.019(8)
N(4)–Ir(2)– N(3) (trans bond length) 2.038(7)⋯1.997(8)
   

Bond angle (°)
N(4)–Ir(2)–N(3) (trans bond angle) 171.3(3)
N(2)–Ir(1)–N(1) (trans bond angle) 172.3(3)
Ir(1)–O(1)–Ir(2) 124.6(3)
N(6)–Ir(2)–O(1) 81.4(2)
N(5)–Ir(1)–O(1) 81.0(2)
N(3)–Ir(2)–C(33) 80.1(4)
N(4)–Ir(2)–C(44) 79.9(3)
N(2)–Ir(1)–C(12) 80.2(3)
N(1)-Ir(1)-C(11) 79.9(3)


Detailed characterization of both complexes 1 and 2 has been carried out by various analytical techniques such as FT-IR, 1H NMR, 13C NMR, COSY NMR (1H–1H), HSQC NMR (1H–13C) and ESI-MS. The 1H NMR spectrum of both complexes 1 and 2 shows a sharp singlet peak at 6.00 ppm and 5.97 ppm, respectively, corresponding to the pyrazole (–CH11) proton (Fig. S3 and S4, SI). The pyrazole (–CH11) acts as a characteristic peak for the identification of both compounds. Methoxy substituents in both 1 and 2 show a singlet with a chemical shift value of 3.65 ppm (Fig. S3 and S4, SI).

In the COSY NMR (1H–1H) for complex 1 (Fig. S5, SI), two distinct doublets appear at 8.27 ppm and 7.90 ppm in the downfield region of the spectra attached to electronegative nitrogen heteroatoms corresponding to (H1 and H1′) and both the protons cross-couple with (H2 and H2′) at 6.51 ppm and 6.76 ppm. Two doublets appear in the upfield region at 5.60 ppm and 5.80 ppm, corresponding to protons H5 and H5′ showing cross-coupling with (H6 and H6′). Aromatic protons of the phenyl ring H10 and H9 (pyrazole) appear at 6.15 ppm and 6.32 ppm, cross-couple with each other, and split into two intense doublets. The 1H–1H couple NMR spectrum of 2 (Fig. S6, SI) shows two sharp singlets appearing at 1.83 ppm and 1.88 ppm in the aliphatic region corresponding to CH3(7) and CH3(7′) protons. In the aromatic region, two sharp singlets appear at 5.62 ppm and 5.45 ppm, and these peaks correspond to phenyl ring proton H8 and H8, (cyclometalating ligand). Proton (H1 and H1′) cross couple with (H2 and H2′). Proton H9 and H10 cross-couple with each other and show intense doublets at 6.18 ppm and 6.30 ppm.

Broad band in the IR spectra of 12 around 3450 cm−1 indicated the presence of the µ-OH group.48 However, adventitious moisture in KBr pellets used for IR spectral measurements can also produce a similar broad O–H stretching band, rendering IR evidence alone inconclusive. Consequently, 1H NMR spectroscopy, specifically D2O exchange experiments were employed to confirm the presence of a bridging hydroxide. In the 1H NMR spectra, the bridging hydroxide protons appear as distinct sharp singlets in the upfield region at −2.03 ppm for complex 1 and −2.21 ppm for complex 2.48a This upfield shift is likely due to the ring current from the metalated ligand, combined with the use of dry DMSO as the solvent. Upon the addition of 100 µL of D2O, these resonances disappeared completely (Fig. S11 and S12, SI). This successful deuterium exchange confirms the labile nature of the protons and provides definitive evidence for the bridging hydroxide moiety. The bridging-OH group arises presumably by hydrolysis of the bridging-OMe group originating from NaOMe used in the reaction.

ESI-MS of both the complexes showed molecular ion peaks as well as [M–OH]+peaks (Fig. S13 and S14, SI). To evaluate the solution stability of the complexes, we performed 1H NMR measurements of complex 1 at three different time intervals: immediately after sample preparation (0 h), after 48 hours, and after 72 hours in CDCl3 at room temperature. The spectra displayed sharp and well-resolved resonances throughout, with no signs of peak broadening, chemical shift changes, or the appearance of new signals indicative of decomposition. These observations confirm that the complex remains intact in solution over the monitored period, supporting its stability under these conditions (Fig. S15, SI).

Photophysical properties in the solution state

The absorption and steady state emission spectra of complexes 1 and 2 were recorded at room temperature in aerated 10−5 M dichloromethane solution (Fig. 2 and 3, Table 3). The absorption as well as emission spectral profiles for both the complexes look similar. Both the complexes display intense absorption in the ultraviolet range, between 260 and 300 nm (with molar absorptivity exceeding ε > 104 M−1 cm−1), attributed to π–π* transitions/spin allowed 1LC within the cyclometalating and ancillary ligand. Additionally, low-energy bands with moderate intensity extending into the visible region, approximately in the wavelength range 350–450 nm, arise from spin-allowed charge transfer transitions. Spin–orbit coupling effects due to the Ir(III) metal center give rise to spin-forbidden transitions, which manifest in the range 450–480 nm, albeit with a lower extinction coefficient. These band assignments were validated through TDDFT (Time dependent density funactional theory) calculations conducted on 1 and 2, utilizing ground state optimized geometry (Tables S2–S5, SI). The absorption spectral profile and intensity of the bands align with previous findings on bridged dinuclear complexes.49–52
image file: d6ra00878j-f2.tif
Fig. 2 Absorption spectra of complexes 1 and 2 in dichloromethane solution (10−5 M) at room temperature.

image file: d6ra00878j-f3.tif
Fig. 3 Emission spectra of complexes 1 and 2 in dichloromethane solution (10−5 M) at room temperature (λexc: 450 nm).
Table 3 Photophysical properties of 12 at 25 °C
Complex Absorptiona λmax (nm); 10−4 ε (M−1 cm−1) Emissiona λmax (nm) Solid-state emissionb λmax (nm) Φc
a Spectral data for both the complexes were recorded in 10−5 M dichloromethane solution at room temperature, for emission (λexc = 450 nm).b Solid state emission recorded at λexc = 450 nm.c Quantum yields were determined using [Ir(ppy)2(bpy)]PF6 (ΦCH3CN = 0.0622) as reference in aerated solution.
1 265(17.1), 352(1.74), 418(0.89), 473(0.46) 550 564 0.06
2 269(9.41), 354(1.32), 414(0.70), 463(0.40) 546 564 0.05


The precursor dimer complex [Ir(ppy)2Cl]2, (for complex 1) displays a very weak emission at 520 nm.53 In comparison, complexes 1 and 2, which are asymmetrically bridged cyclometalated Ir(III) dimers, [(ppy)2Ir(µ-OH){µ-(PhOMe)2Pz}Ir(ppy)2] and [(tpy)2Ir(µ-OH){µ-(PhOMe)2Pz}Ir(tpy)2] respectively, exhibit single, broad, featureless emission bands centered at 550 nm and 546 nm (Fig. 3). This represents a red shift in the emission relative to the precursor complex [Ir(ppy)2Cl]2. Since the bridging ancillary 3,5-bis(4-methoxyphenyl)-pyrazolate ligand contributes minimally to the HOMO and LUMO, the observed red shift is likely attributable to the bridging OH. The photoluminescence spectra of diiridium complexes bridged by oxamidato ligands reported by Bryce and co-workers display broad, well-defined, and featureless peaks, resembling those observed for complexes 1 and 2.54 Zysman-Colman and co-workers reported a series of four formyl-substituted µ-dichloro bridged iridium(III) dimers.53 Structurally, however, the complexes reported differ from complexes 1 and 2. Among these, two complexes displayed emission profiles as single, broad, featureless bands similar to those of complexes 1 and 2, though their emission maxima differed. Such emission features are characteristic of dominant 3MLCT (metal to ligand charge transfer) character with minimal contribution from ligand-centred 3LC (ligand-centred) states. DFT calculations on the aforementioned formyl-substituted µ-dichloro bridged iridium(III) dimers revealed that the HOMO is distributed across the iridium dimer with substantial electron density localized on the iridium centers, the phenyl rings of the cyclometalating ligands, and the µ-Cl bridge. This distribution signifies effective electronic communication between the two iridium atoms mediated by the µ-Cl bridge, analogous to the role of the µ-OH bridge in our complexes. Overall, the emission spectra features correspond well with existing literature observations.53,55 However, the modification of the pyrazole ligand backbone by introduction of a methoxy substituent (–OMe) does not exert any clear effect on the photophysical properties. The quantum yields of the complexes are 0.06 to 0.05 for 1 and 2, respectively, which were determined relative to the complex [Ir(ppy)2(bpy)]PF6 (ΦCH3CN = 0.0622) in optically dilute solutions.56 The chloro-bridged Ir(III) precursor complexes are known to be poorly emissive; thus in the current instance, complexes 1 and 2 are better emitters compared to their parent complex. The quantum yields observed for 1 and 2 are also comparable with previous findings in the literature.57–59 Diiridium cyclometalated Ir(III) complexes are generally characterized by low photoluminescent quantum yields. Although the complexes presented in this work show enhanced quantum yields compared to some literature examples, their values remain in the low range and are still lower than those observed for mononuclear Ir(III) complexes.

It must be emphasized at this point that even though the photophysical properties of the resultant complexes could not be tuned by modification of the ancillary ligand structure, the overall importance of the ancillary ligand cannot be undermined. In our particular case, the steric effect of the ancillary 3,5-bis(4-methoxyphenyl)-pyrazole ligand plays an important role in the overall assembly of the dimeric cyclometalated Ir(III) complexes. Earlier studies have shown that, using the same experimental conditions as those employed for the synthesis of complexes 1 and 2, the reaction of [(ppy)2Ir(µ-Cl)]2 with 3(5)-methyl-5(3)-phenyl pyrazole (PhMePzH) yields a cyclometalated heterobridged Ir(III) dimer, [(ppy)2Ir(µ-OH)(µ-PhMePz)Ir(ppy)2], along with a heteroleptic monomer, [(ppy)2Ir(PhMePz)Cl].37 This outcome suggests that reducing the steric bulk of the ancillary ligand leads to the formation of a product mixture. The emission spectrum of the aforementioned heterobridged dimer, which contains a bridging –OH group, exhibits a single emission band at 550 nm similar to that observed for complexes 1 and 2. In contrast, the heteroleptic mononuclear complex, which lacks the bridging –OH, shows vibronically structured emission bands with an emission maximum at 497 nm. This highlights the influence of the bridging –OH ligand, as evidenced by the redshift in the emission spectrum.

Theoretical calculations

DFT and TDDFT calculations on complex 1 and 2 were conducted to probe their observed photophysical properties and also to understand the impact of methoxy substitution on the ancillary pyrazole ligand backbone.

The key optimized geometry parameters for 1 and 2 in the ground state (S0) at the PBE0 level, together with the experimental value for 1 is shown in Table S1 (SI). The optimized structure obtained by DFT calculations of complex 1 is shown in Fig. 4, which shows that the complex exhibits a distorted octahedral geometry. For complex 1, the calculated Ir–C bond lengths are 2.000 and 1.999 Å, which align closely with the experimental values of 2.011 and 2.007 Å, respectively. The calculated Ir–N trans bond lengths are 2.032, 2.021, 2.032, and 2.020 Å, while the corresponding experimental values are 2.050, 2.064, 2.038, and 1.997 Å. For the bridging pyrazolate ligands, the calculated Ir–N distances are 2.170 and 2.172 Å, while the experimental values are 2.187 and 2.201 Å. The Ir–O and non-bonding Ir⋯Ir distances are calculated as 2.118–2.119 Å and 3.782 Å, respectively, whereas the experimental measurements are 2.147–2.143 Å and 3.798 Å. The calculated bond angles also show good agreement with experimental data. For complex 2, no experimental structural data are available. However, its calculated structural parameters show a strong correlation with the experimental values observed for complex 1, suggesting an identical structural arrangement. In complex 2, the calculated Ir–C bond lengths are 2.000 and 2.001 Å, while the Ir–N bond lengths in the trans positions are 2.033, 2.022, 2.022, and 2.034 Å. For the bridging pyrazolate ligands, the Ir–N distances are calculated to be 2.165 and 2.177 Å. The Ir–O bond length and the non-bonding Ir⋯Ir separation are determined to be 2.117 Å and 3.781 Å, respectively. The trans N–Ir–N and Ir–O–Ir bond angles are approximately 172.0° and 126.5°, respectively. All other calculated bond angles also closely match the experimental values of 1, supporting the conclusion that both iridium centers adopt a distorted octahedral geometry. DFT optimized structure of 2 is given in Fig. S17.


image file: d6ra00878j-f4.tif
Fig. 4 Optimized geometry parameters of complex 1 in the ground state (S0) at the PBE0/LANL2TZ/D95V level.

The frontier molecular orbital compositions of complex 1 are given in Table 4. Some selected molecular orbitals with the contour plots are depicted in Fig. 5. The computational results indicate that HOMO, HOMO−1 and HOMO−2 predominantly reside on the cyclometalated ligand (2-phenylpyridine) and the iridium atom, whereas the LUMO, LUMO+1 and LUMO+2 orbitals are primarily concentrated on the cyclometalated ligand. This orbital distribution aligns well with the anticipated characteristics of these complexes and also with literature reports.60,61 The bridging ancillary 3,5-bis(4-methoxyphenyl)-pyrazolate ligand contributes minimally to both the HOMO and LUMO. However, the HOMO−2 orbital is significantly concentrated on the bridging hydroxide ligand (16.1%). Thus, the use of a methoxy substituent on the pyrazole ligand backbone has minimal effect on the tuning of the HOMO–LUMO gap. The computational results of 2 are given in SI (Fig. S17 and S18). Frontier molecular orbitals of 2 resemble those of 1. This indicates that varying the substituents on the cyclometalated ligand (C^N), such as adding a methyl group in the phenyl ring of the C^N ligand, does not have any significant effect on the spectral properties.

Table 4 Molecular orbital composition (%) in the ground state at the PBE0/LANL2TZ/D95V level for complex 1
Orbital Energy (eV) Main bond nature
LUMO+3 −1.137 LC (92.0%)
LUMO+2 −1.207 LC (92.3%)
LUMO+1 −1.306 LC (93.7%)
LUMO −1.491 LC (93.8%)
HOMO −4.930 Ir-d (35.3%) + LC (51.9%)
HOMO−1 −5.052 Ir-d (38.9%) + LC (45%)
HOMO−2 −5.091 Ir-d (38.3%) + LC (38.1%) + LOH (16.1%)
HOMO−3 −5.478 Ir-d (37.3%) + LC (27.7%) + LA (32.8%)



image file: d6ra00878j-f5.tif
Fig. 5 Relevant molecular orbitals of complex 1 (iso value = 0.04) obtained from DFT calculations at the PBE0/LANL2TZ/D95V level.

TDDFT calculations were also performed for both 1 and 2 by utilizing the polarizable continuum model (PCM) with dichloromethane as the solvent. The results show good correlation with experimentally obtained data, albeit with some deviations (Tables S2–S5, SI). The lowest energy singlet absorption is dominated by Ir(d) + LC → LC transitions, which can be assigned to mixed MLCCT, ILCCT character. The lowest singlet–triplet excitation energies exhibit MLCCT, ILCCT, and LOHLCCT nature. Importantly, the bridging 3,5-bis(4-methoxyphenyl)-pyrazolate ligand has little involvement in the lowest-energy excited states, indicating that substituent changes on this ligand are unlikely to substantially alter the spectroscopic characteristics of the complexes.

Electrochemical studies

Electrochemical properties of complexes 12 were studied by cyclic voltammetry (CV), which was conducted in dry dichloromethane solvent (Fig. 6, Table 5). The complexes display two consecutive one-electron steps (redox couple) corresponding to IrIVIrIII/IrIIIIrIII and IrIVIrIV/IrIVIrIII. Complexes 1 and 2 differ in the substitution pattern of the cyclometalating phenylpyridine ligands. This difference affects their oxidation potentials: methyl-substituted complex 2 [(tpy)2Ir(µ-OH){µ-(PhOMe)2Pz}Ir(tpy)2] is oxidized at a more negative potential (0.58 V, couple 1 and 0.93 V, couple 2) compared to unsubstituted complex 1 [(ppy)2Ir(µ-OH){µ-(PhOMe)2Pz}Ir(ppy)2] (0.64 V, couple 1 and 0.99 V, couple 2) versus Ag+/Ag, respectively. For the previously reported heterobridged complexes lacking methoxy substituents, oxidation peaks were observed at 0.62 V (couple 1) and 0.95 V (couple 2).37 The corresponding methoxy-substituted complex (Complex 1) exhibits nearly identical redox potentials, indicating that the introduction of the methoxy group exerts only a minor electronic effect. Although methoxy substituents are typically electron-donating through mesomeric effect and are expected to shift the reduction potential negatively, in this system, the methoxy groups are pendant and not directly attached to the pyrazole ring. As a result, their electron-donating contribution is minimal. Complex 1 exhibit reversible electrochemical behaviour, while complex 2 displays quasi-reversible behaviour. Within the accessible potential range of the solvent, no reduction processes occurred.
image file: d6ra00878j-f6.tif
Fig. 6 Cyclic voltammogram of complexes 1, 2 recorded at room temperature in dichloromethane (1 mM) containing 0.1 M TBAPF6 electrolyte, with a scan rate of 100 mV s−1, starting from 0.0 V.
Table 5 Half-wave redox potentials (vs. Ag/AgNO3) of 12 at 25 °C
Complex E11/2,ox/VaEp/mV)b E21/2,ox/VaEp/mV)b
a Recorded in dichloromethane solution containing 0.001 M iridium complexes, E1/2 = 1/2(Epa + Epc), where Epa and Epc are anodic and cathodic peak potentials, respectively.b ΔEp = EpaEpc.c The Fc+/Fc redox couple is used as an internal standard reference.
1 0.64 (115) 0.99 (120)
2 0.58 (156) 0.93(150)
E° (Fc+/Fc)c 0.50 (120)


Rocha and co-workers reported a mixed µ-pyrazolate and µ-alkoxide bridged dimer of Ru(bpy)2 moiety.50 The cyclic voltammogram of the complex in acetonitrile exhibited two one-electron oxidation processes at 0.09 and 0.71 V versus Ag+/Ag, with a large peak separation (ΔEp) of 620 mV. Large comproportionation constant (Kc) value of 3.0 × 1010 indicated strong electronic communication between the two redox centers.50 Chandrasekhar et al. reported heterobridged cyclometalated Ir(III) dimers featuring substituted pyrazolate and hydroxy bridges.37 These complexes displayed two sequential one-electron oxidation steps with moderate peak separations of 332, 338, and 368 mV. Comparable behaviour is observed for our heterobridged iridium(III) complexes. The separation between redox couples (ΔE1/2) for complex 1 is 340 mV and for complex 2 is 350 mV, which gives a comproportionation constant (Kc) of 5.6 × 105 and 8.3 × 105, respectively. This indicates a stabilized mixed valence state of IrIVIrIII, which, according to Robin-Day classification, belongs to class II, characterised by moderate electronic coupling.49,62 This also indicates communication between the two iridium centers, which may be aided by the presence of a bridging hydroxide ligand. In contrast, the parent dimer [Ir(ppy)2Cl] exhibits two one-electron oxidation waves with a smaller peak separation of 260 mV, indicating weaker metal–metal interaction mediated by the µ-Cl bridges.53

Conclusions

In this study, we have presented heterobridged cyclometalated Ir(III) dimers featuring substituted pyrazole and hydroxide bridges. Introduction of a methoxy substituent in the ancillary pyrazole ligand backbone affords dimeric complexes as anticipated; however, the methoxy substituent does not exert any significant effect on the photophysical properties.

The emission spectra of the heterobridged dimers 1 and 2, which feature a bridging –OH group, display characteristics similar to those of previously reported heterobridged analogues such as [(ppy)2Ir(µ-OH)(µ-PhMePz)Ir(ppy)2] and [(tpy)2Ir(µ-OH)(µ-Ph2Pz)Ir(tpy)2]. These dimeric complexes show a single emission peak centered around 550 nm. In contrast, reported heteroleptic mononuclear complexes like [(ppy)2Ir(PhMePz)Cl] and [(ppy)2Ir(PhMePz)OH], which contain terminal chloride and hydroxide groups, exhibit vibronically structured emission bands with maxima at 497 nm and 513 nm, respectively. This indicates that incorporating a hydroxide bridge leads to a bathochromic shift in the emission bands.

Theoretical DFT and TDDFT calculations provided additional insights into the photophysical properties of these compounds, confirming that only the µ-OH bridge influences the HOMO levels in the diiridium complexes.

Electrochemical investigations further highlight that only the µ-OH bridge plays an important role in facilitating metal–metal communication within the diiridium complexes. Although the ancillary pyrazole ligand does not significantly affect the photophysical properties, it remains an important component of the complexes. These ligands are essential for the stability and formation of the overall structure of the complexes. Since the methoxy groups are located at the para positions of the peripheral phenyl rings rather than directly on the pyrazolate scaffold, their electronic impact on the complex is expected to be minimal. These substituents were mainly introduced at this position to facilitate the formation of dimeric complexes, as the less bulky groups tends to yield monomeric complexes and product mixtures. The added steric hindrance improves the ease of isolation of diiridium species, and directs the reaction towards the formation of a single, well defined dimer instead of a mixture of products. Incorporating substituents with greater ability to influence electronic properties such as C6H4-4-NO2 (σ = 0.25), could result in more significant changes in the photophysical properties. Exploring such electronically tuned systems is a promising direction, and we intend to pursue this in future studies.

Overall, our findings underscore the significant impact of the bridging ligand on the electronic structure and spectroscopic properties of these Ir(III) dimers, offering new perspectives for the basic understanding of structure and photophysical properties of this emerging class of compounds and might steer further direction for their potential applications in various fields.

Experimental section

General

2-Phenylpyridine was purchased from Sigma Aldrich, while 2-(p-tolyl)pyridine, 3,5-bis(4-methoxyphenyl)-pyrazole, hydrazine hydrate, and iridium trichloride hydrate were obtained commercially from TCI and were used as such without further purification. Solvents were purified using standard methods and freshly distilled under an inert atmosphere before use, following established procedures. Freshly prepared sodium methoxide was used in the reactions.

Instrumentation

For complex 1, 1H NMR was recorded at 600 MHz (Bruker Avance neo). 13C spectra for both 1 and 2 were obtained at 150 MHz. Tetramethylsilane [Si(CH3)4] was used as the reference. ESI-HR mass analyses were performed on a Waters Micromass Quattro Micro triple quadrupole mass spectrometer in solutions of compounds 1 and 2 in acetonitrile with 20% formic acid. IR spectra (range 4000–400 cm−1) were recorded on a Bruker FT-IR spectrometer as KBr pellets. UV-visible spectra were recorded at room temperature in a Shimadzu UV-1900i UV-vis spectrophotometer in a Shimadzu Eco Cell 10 mm quartz cuvette. C, H and N analyses were carried out in a Euro EA 3000 CHNS-O analyzer. A Cary Eclipse spectrophotometer was used for the measurement of steady-state emission spectra. Quantum yields were determined using [Ir(ppy)2(bpy)]PF6 (ΦCH3CN = 0.0622) as the reference compound. Solvents used were all of spectroscopic grade. Cyclic voltammetry studies were performed at room temperature in Palmsens 4 electrochemical workstation using a standard three-electrode electrochemical cell. Platinum electrode (size 3 mm) was used as a working electrode, Ag/AgNO3 as reference electrode (3 M KNO3), and a platinum-wire as counter electrode. The studies were carried out using 0.1 M [n-Bu4N][PF6] in dichloromethane solutions (dry) of the complexes (1 mM) under nitrogen atmosphere.63 Ferrocene (Fc+/Fc) was used as an internal standard (E° = 0.50 V in dichloromethane).

Computational details

Complex 1 was modelled using Gaussian 03.64 Geometry optimization in the ground state was performed in the gas phase considering the singlet ground state (S0) by the PBE0 density functional theory (DFT) method.65,66 Further, vibrational frequency calculation was carried out at the optimized geometry so as to confirm potential energy minima. Frequency calculations showed the absence of imaginary frequencies. The pseudopotential of LANL2TZ basis set and a triple zeta quality basis set LANL2TZ was taken for iridium atoms,67 D95V basis set was used on all the non-metal atoms.68 Gauss view was used for the visualization of orbital surfaces. Vmodes was used to determine the percentage contributions of the iridium center and ligands (cyclometalating, ancillary, and –OH) to the respective orbitals.69 TDDFT calculations were performed with the optimized geometry at the PBE0/LANL2DZ/D95V level of theory by means of the PCM (Polarizable Continuum Model) solvation model in dichloromethane solution.70 Similar calculations were performed for complex 2 as well.

X-ray crystallography

X-ray diffraction data were collected at 293 K on an XtaLAB Synergy Dualflex diffractometer equipped with a HyPix3000 detector, using Cu Kα radiation (λ = 1.54184 Å). The crystal structure was solved by direct methods using Olex 2 (v2.0).71 Full-matrix least-squares refinement on F2 was performed, with all non-hydrogen atoms refined anisotropically. Hydrogen atoms bonded to carbon were placed in geometrically calculated positions and refined using a riding model with default parameters in SHELXL.72 The structure was solved and refined as a two component twin, with 12[thin space (1/6-em)]380 and 4156 reflections respectively. The remaining residual electron density corresponds to Fourier ripples, with two residual peaks located at equal distances from each iridium centers. The hydrogen atom bonded to the bridging oxygen could not be located in the Fourier difference map, most likely due to the dominance of the heavy iridium atoms, which limits the detection of light atoms. Attempts to include this hydrogen atom using restraints (DFIX, DANG) did not result in a stable refinement and were therefore omitted. The presence of a bridging –OH group is, however, supported by 1H NMR studies. Disordered solvent molecules could not be modelled directly. Therefore ‘mask’ was used for modelling. The suggested cavity and number of electrons indicated the presence of one dichloromethane and two methanol molecules. The crystallographic data for complex 1 have been submitted to the Cambridge Crystallographic Data Centre via CCDC number 2415220.

Synthesis

Synthesis of [(ppy)2Ir(µ-OH){µ-(PhOMe)2Pz}Ir(ppy)2] (1).
Procedure. The diiridium complex [(ppy)2Ir(µ-Cl)]2 (0.10 g, 0.093 mmol) was dissolved in 30 mL of dichloromethane, followed by the addition of sodium methoxide (0.025 g, 0.47 mmol). The reaction mixture was stirred under a nitrogen atmosphere at room temperature for 2 hours, during which the color of the reaction mixture changed from yellow to orange. Subsequently, the ancillary ligand 3,5-bis(4-methoxyphenyl) pyrazole (0.031 g, 0.11 mmol) was added, and the mixture was stirred for further 12 hours at room temperature. After completion, the solvent was removed under reduced pressure, yielding an oily residue. The addition of diethyl ether induced precipitation of a yellow solid, which was collected by filtration, washed with methanol, and dried. The yield was found to be 0.082 g, 68%.
Characterization data. 1H NMR (600 MHz, DMSO-d6): δ 8.21 (d, J = 8.1 Hz, 2H), 7.99 (d, J = 5.3 Hz, 2H), 7.88 (t, J = 7.6 Hz, 2H), 7.81 (d, J = 8.1 Hz, 2H), 7.73 (t, J = 7.5 Hz, 2H), 7.68 (d, J = 7.6 Hz, 2H), 7.05–6.97 (m, 4H), 6.69 (dd, J = 14.2, 6.5 Hz, 4H), 6.63 (t, J = 6.2 Hz, 2H), 6.43 (t, J = 7.3 Hz, 2H), 6.26 (t, J = 7.2 Hz, 2H), 6.18 (t, J = 8.1 Hz, 6H), 6.11 (d, J = 8.5 Hz, 4H), 6.00 (s, 1H), 5.71 (d, J = 7.6 Hz, 2H), 5.51 (d, J = 7.6 Hz, 2H), 3.65 (s, 6H), −2.03 (s, 1H). 13C NMR (150 MHz, DMSO) δ: 169.36, 168.44, 159.54, 157.71, 152.72, 152.30, 152.05, 146.84, 145.54, 144.76, 137.73, 136.29, 131.24, 130.62, 128.93, 128.39, 127.84, 124.39, 124.30, 122.68, 120.99, 120.49, 119.33, 119.04, 118.30, 113.04, 55.25. ESI-HRMS: m/z 1298.3318, [M]+; m/z 1281.3353, [M–OH]+. IR (KBr, cm−1) 3435(br), 3051(w), 2918(m), 2843(w), 1652(w), 1602(s), 1535(s), 1494(vs), 1427(s), 1393(s), 1301(w), 1218(m), 1177(s), 1102(w), 1027(s), 835(w), 760(m), 627(w). CHN analysis: mol. formula: C61H48Ir2N6O3; calculated: C, 56.47; H, 3.73; N, 6.48. Found: C, 56.83; H, 4.18; N, 6.92.
Synthesis of [(tpy)2Ir(µ-OH){µ-(PhOMe)2Pz}Ir(tpy)2] (2). The synthetic procedure followed was analogous to that of complex 1 with 2-(p-tolyl) pyridine as the cyclometalating ligand instead of 2-phenyl pyridine. Quantities involved were as follows:
[(tpy)2 Ir(µ-Cl)]2. (0.100 g, 0.088 mmol), sodium methoxide (0.023 g, 0.44 mmol), 3,5-bis(4-methoxyphenyl)-pyrazole (0.029 g 0.10 mmol). The yield was found to be 0.079 g, 67%.
1H NMR (600 MHz, DMSO-d6). δ 8.12 (d, J = 8.1 Hz, 2H), 7.92 (d, J = 5.2 Hz, 2H), 7.82 (t, J = 7.6 Hz, 2H), 7.71 (t, J = 9.8 Hz, 2H), 7.67 (t, J = 7.5 Hz, 2H), 7.55 (d, J = 7.8 Hz, 2H), 6.95 (t, J = 6.3 Hz, 2H), 6.90 (d, J = 7.8 Hz, 2H), 6.65 (d, J = 5.3 Hz, 2H), 6.56 (t, J = 6.1 Hz, 2H), 6.50 (d, J = 7.6 Hz, 2H), 6.16 (t, J = 14.9 Hz, 4H), 6.10 (d, J = 8.2 Hz, 4H), 6.06 (d, J = 7.7 Hz, 2H), 5.97 (s, 1H), 5.52 (s, 2H), 5.29 (s, 2H), 3.65 (s, 6H), 1.78 (s, 6H), 1.75 (s, 6H), −2.21 (s, 1H). 13C NMR (150 MHz, CDCl3) δ: 170.19, 169.60, 159.86, 157.91, 153.26, 152.76, 147.91, 142.56, 142.10, 139.25, 137.87, 136.32, 135.05, 133.06, 132.30, 129.60, 129.44, 124.36, 123.73, 122.26, 121.60, 120.17, 119.45, 118.23, 117.68, 113.08, 111.73, 55.66, 22.18, 22.08. ESI-HRMS: m/z 1354.3696, [M]+; m/z 1337.3612, [M–OH]+. IR (KBr, cm−1) 3435(br), 3018(w), 2918(w), 2842(w), 1744(w), 1602(m), 1527(s), 1485(vs), 1427(s), 1310(w), 1218(m), 1168(m), 1027(w), 1127(w), 1018(m), 835(w), 767(m), 618(w). CHN analysis: mol. formula: C65H56Ir2N6O3; calculated: C, 57.68; H, 4.17; N, 6.21; found: C, 57.94; H, 4.72; N, 6.85.

Conflicts of interest

The authors declare no conflict of interest.

Data availability

CCDC 2415220 contains the supplementary crystallographic data for this paper.73

The data supporting this article have been included as part of the supplementary information (SI). Supplementary information: IR spectra, NMR spectra, ESI-MS spectra, solid-state emission spectra, cyclic voltammetry plot and computational results. See DOI: https://doi.org/10.1039/d6ra00878j.

Acknowledgements

The authors thank funding from Science and Engineering Research Board, India, New Delhi (FILE No. CRG/2021/000980-G) and IoE (Banaras Hindu University, Scheme No. 6031/2020-21) for generously funding the research. We thank Prof. Subrato Bhattacharya and Dr Divya Kushwaha for valuable discussions.

References

  1. K. A. King, P. J. Spellane and R. J. Watts, J. Am. Chem. Soc., 1985, 107, 1431–1432 CrossRef CAS.
  2. D. L. Ma, S. Lin, W. Wang, C. Yang and C. H. Leung, Chem. Sci., 2017, 8, 878–889 RSC.
  3. M. K. Nazeeruddin, R. Humphry-Baker, D. Berner, S. Rivier, L. Zuppiroli and M. Graetzel, J. Am. Chem. Soc., 2003, 125, 8790–8797 CrossRef CAS.
  4. M. Z. Shafikov, A. V. Zaytsev and V. N. Kozhevnikov, Inorg. Chem., 2024, 63, 1317–1327 CrossRef CAS.
  5. L. E. Cells, K. Nazeeruddin, R. T. Wegh, Z. Zhou, C. Klein, Q. Wang, F. De Angelis, S. Fantacci and M. Grätzel, Inorg. Chem., 2006, 45, 9245–9250 CrossRef PubMed.
  6. Y. You, S. Cho and W. Nam, Inorg. Chem., 2014, 53, 1804–1815 CrossRef CAS PubMed.
  7. Y. You, S. Lee, T. Kim, K. Ohkubo, W. S. Chae, S. Fukuzumi, G. J. Jhon, W. Nam and S. J. Lippard, J. Am. Chem. Soc., 2011, 133, 18328–18342 CrossRef CAS PubMed.
  8. Q. Zhao, M. Yu, L. Shi, S. Liu, C. Li, M. Shi, Z. Zhou, C. Huang and F. Li, Organometallics, 2010, 29, 1085–1091 CrossRef CAS.
  9. S. Lee and W. Han, Inorg. Chem. Front., 2020, 7, 2396–2422 RSC.
  10. C. Wu, K. Shi, S. Li, J. Yan, Z.-Q. Feng, K.-N. Tong, S.-W. Zhang, Y. Zhang, D. Zhang, L.-S. Liao, Y. Chi, G. Wei and F. Kang, Energy Chem., 2024, 6, 100120 CrossRef CAS.
  11. (a) Q. Yang, X. Yang, Y. Wang, Y. Fei, F. Li, H. Zheng, K. Li, Y. Han, T. Hattori, P. Zhu, S. Zhao, L. Fang, X. Hou, Z. Liu, B. Yang and B. Zou, Nat. Commun., 2024, 15, 7778 CrossRef CAS PubMed; (b) Z. K. Qin, Y. K. Zhang, H. Tian, Z. C. Pan, M. Q. Wang, L. Cui, J. Y. Wang, L. X. Bao, Y. H. Wang, W. Y. Zhang and M. X. Song, RSC Adv., 2024, 14, 36895–36901 RSC.
  12. M. A. Baldo, M. E. Thompson and S. R. Forrest, Pure Appl. Chem., 1999, 71, 2095–2106 CrossRef CAS.
  13. S. Lamansky, P. Djurovich, D. Murphy, F. Abdel-Razzaq, R. Kwong, I. Tsyba, M. Bortz, B. Mui, R. Bau and M. E. Thompson, Inorg. Chem., 2001, 40, 1704–1711 CrossRef CAS PubMed.
  14. I. Soriano-Díaz, I. D. Dergachev, S. A. Varganov, E. Ortí and A. Giussani, J. Phys. Chem. Lett., 2025, 16, 9004–9010 CrossRef.
  15. T. Sajoto, P. I. Djurovich, A. B. Tamayo, J. Oxgaard, W. A. Goddard III and M. E. Thompson, J. Am. Chem. Soc., 2009, 131, 9813–9822 CrossRef CAS PubMed.
  16. A. Omist, I. D. Dergachev, S. A. Varganov, E. Ort and A. Giussani, Inorg. Chem., 2025, 64, 8313–8321 CrossRef PubMed.
  17. I. Soriano-Díaz, I. D. Dergachev, S. A. Varganov, E. Ortí and A. Giussani, J. Phys. Chem. Lett., 2025, 16, 9004–9010 CrossRef PubMed.
  18. J. M. Younker and K. D. Dobbs, J. Phys. Chem. C, 2013, 117, 25714–25723 CrossRef CAS.
  19. M. Spiegel, Int. J. Mol. Sci., 2025, 26, 5062 CrossRef CAS PubMed.
  20. K. S. Bejoymohandas, A. Baschieri, F. Reginato, S. Toffanin, M. Prosa, E. Bandini, A. Mazzanti and F. Monti, Adv. Opt. Mater., 2024, 12, 2401586 CrossRef CAS.
  21. E. Baranoff, S. Fantacci, F. De Angelis, X. Zhang, R. Scopelliti, M. Grätzel and M. K. Nazeeruddin, Inorg. Chem., 2011, 50, 451–462 CrossRef CAS.
  22. N. Singh, G. H. Noh, H. Mubarok, C. W. Kim, M. H. Lee and J. Lee, Polyhedron, 2022, 227, 116096 CrossRef CAS.
  23. A. Baschieri, L. Sambri, A. Mazzanti, A. Carlone, F. Monti and N. Armaroli, Inorg. Chem., 2020, 59, 16238–16250 CrossRef CAS PubMed.
  24. E. M. Vollbert, C. Ciambrone, W. Lafargue-dit-hauret, C. Latouche, F. Loiseau and P. H. Lanoe, Inorg. Chem., 2022, 61, 3033–3049 CrossRef.
  25. E. A. Katlenok, A. V Rozhkov, R. R. Ramazanov, R. R. Valiev, O. V Levin, D. O. Goryachiy, I. V Taydakov, M. L. Kuznetsov and V. Y. Kukushkin, Inorg. Chem., 2022, 61, 8670–8684 CrossRef CAS PubMed.
  26. L. Skorka, M. Filapek, L. Zur, J. G. Malecki, W. Pisarski, M. Olejnik, W. Danikiewicz and S. Krompiec, J. Phys. Chem. C, 2016, 120, 7284–7294 CrossRef CAS.
  27. B. Balonova, T. H. Jones, A. E. True, S. M. Hetherington and B. A. Blight, RSC Adv., 2024, 14, 34288–34297 RSC.
  28. K. Choroba, J. Palion-gazda, M. Penkala, P. Rawicka and B. Machura, Dalton Trans., 2024, 2, 17934–17947 RSC.
  29. C. Jiang and T. S. Teets, Inorg. Chem. Front., 2024, 11, 1501–1510 RSC.
  30. P. Gayen, U. Das and S. Banerjee, J. Phys. Chem. A, 2020, 124, 4654–4665 CrossRef CAS PubMed.
  31. J. Li, P. I. Djurovich, B. D. Alleyne, M. Yousufuddin, N. N. Ho, J. C. Thomas, J. C. Peters, R. Bau and M. E. Thompson, Inorg. Chem., 2005, 44, 1713–1727 CrossRef CAS.
  32. Y. You and S. Y. Park, J. Chem. Soc., Dalton Trans., 2009, 9226, 1267–1282 RSC.
  33. R. Mukherjee, Coord. Chem. Rev., 2000, 203, 151–218 CrossRef CAS.
  34. M. Viciano Chumillas, S. Tanase, L. J. de Jongh and J. Reedijk, Eur. J. Inorg. Chem., 2010, 2010, 3403–3418 CrossRef.
  35. T. Hajra, J. K. Bera and V. Chandrasekhar, Aust. J. Chem., 2011, 64, 561–566 CrossRef CAS.
  36. M. A. Halcrow, Dalton Trans., 2009, 9226, 2059–2073 RSC.
  37. V. Chandrasekhar, B. Mahanti, P. Bandipalli and K. Bhanuprakash, Inorg. Chem., 2012, 51, 10536–10547 CrossRef CAS PubMed.
  38. J. L. Liao, P. Rajakannu, P. Gnanasekaran, S. R. Tsai, C. H. Lin, S. H. Liu, C. H. Chang, G. H. Lee, P. T. Chou, Z. N. Chen and Y. Chi, Adv. Opt. Mater., 2018, 6, 1800083 CrossRef.
  39. G. Comas-Vilà and P. Salvador, Phys. Chem. Chem. Phys., 2025, 27, 10482–10491 RSC.
  40. C. Hansch, A. Leo and R. W. Taft, Chem. Rev., 1991, 91, 165–195 CrossRef CAS.
  41. K. Hasan, A. K. Bansal, I. D. W. Samuel, C. Roldán-Carmona, H. J. Bolink and E. Zysman-Colman, Sci. Rep., 2015, 5, 12325 CrossRef CAS PubMed.
  42. D. L. Davies, M. P. Lowe, K. S. Ryder, K. Singh and S. Singh, Dalton Trans., 2011, 40, 1028–1030 RSC.
  43. X. Yang, X. Xu, J. Dang, G. Zhou, C.-L. Ho and W.-Y. Wong, Inorg. Chem., 2016, 55, 1720–1727 CrossRef CAS PubMed.
  44. X. Yang, X. Chen, J. Dang, Y. Sun, Z. Feng, Z. Tian, G. Zhou and Z. Wu, Chem. Eng. J., 2020, 391, 123505–123517 CrossRef CAS.
  45. E. Kabir, Y. Wu, S. Sittel, B.-L. Nguyen and T. S. Teets, Inorg. Chem. Front., 2020, 7, 1362–1373 RSC.
  46. M. Nonoyama, Bull. Chem. Soc. Jpn., 1974, 47, 767–768 CrossRef CAS.
  47. G. Mezei and R. G. Raptis, Inorg. Chim. Acta., 2004, 357, 3279–3288 CrossRef CAS.
  48. (a) F. Scarpelli, A. Ionescu, L. Ricciardi, P. Plastina, I. Aiello, M. La Deda, A. Crispini, M. Ghedini and N. Godbert, Dalton Trans., 2016, 45, 17264–17273 RSC; (b) A. S. Inonkin, Y. Wang, W. J. Marshall and V. A. Petrov, J. Organomet. Chem., 2007, 692, 4809–4827 CrossRef.
  49. D. A. Bardwell, L. Horsburgh, J. C. Jeffery, L. F. Joulic, M. D. Ward, I. Webster and L. J. Yellowlees, J. Chem. Soc. Dalton Trans., 1996, 12, 2527–2531 RSC.
  50. H. Jude, F. N. Rein, P. S. White, D. M. Dattelbaum and R. C. Rocha, Inorg. Chem., 2008, 47, 7695–7702 CrossRef CAS PubMed.
  51. V. Chandrasekhar, T. Haira, J. K. Bera, S. M. W. Rahaman, N. Satumtira, O. Elbjeirami and M. A. Omary, Inorg. Chem., 2012, 51, 1319–1329 CrossRef CAS PubMed.
  52. X. Yuan, S. Zhang and Y. Ding, Inorg. Chem. Commun., 2012, 17, 26–29 CrossRef CAS.
  53. M. Y. Wong, G. Xie, C. Tourbillon, M. Sandroni, D. B. Cordes, A. M. Z. Slawin, I. D. W. Samuel and E. Zysman-Colman, Dalton Trans., 2015, 44, 8419–8432 RSC.
  54. A. M'Hamedi, M. A. Fox, A. S. Batsanov, H. A. Al-Attar, A. P. Monkman and M. R. Bryce, J. Mater. Chem. C, 2017, 5, 6777–6789 RSC.
  55. G. Li, D. G. Congrave, D. Zhu, Z. Su, M. R. Bryce, G. Li, D. G. Congrave, D. Zhu, Z. Su and R. Bryce, Polyhedron, 2018, 140, 146–157 CrossRef CAS.
  56. J. I. Goldsmith, W. R. Hudson, M. S. Lowry, T. H. Anderson and S. Bernhard, J. Am. Chem. Soc., 2005, 127, 7502–7510 CrossRef CAS PubMed.
  57. R. D. Costa, G. Fernández, L. Sánchez, N. Martín, E. Ortí and H. J. Bolink, Chem.–Eur. J., 2010, 16, 9855–9863 CrossRef CAS PubMed.
  58. A. Auffrant, A. Barbieri, F. Barigelletti, J. P. Collin, L. Flamigni, C. Sabatini and J. P. Sauvage, Inorg. Chem., 2006, 45, 10990–10997 CrossRef CAS PubMed.
  59. A. Auffrant, A. Barbieri, F. Barigelletti, J. Lacour, P. Mobian, J. P. Collin, J. P. Sauvage and B. Ventura, Inorg. Chem., 2007, 46, 6911–6919 CrossRef CAS PubMed.
  60. D. Di Censo, S. Fantacci, F. De Angelis, C. Klein, N. Evans, K. Kalyanasundaram, H. J. Bolink, M. Grätzel and M. K. Nazeeruddin, Inorg. Chem., 2008, 47, 980–989 CrossRef CAS PubMed.
  61. R. D. Costa, F. Monti, G. Accorsi, A. Barbieri, H. J. Bolink, E. Ortí and N. Armaroli, Inorg. Chem., 2011, 50, 7229–7238 CrossRef CAS PubMed.
  62. M. B. Robin and P. Day, Adv. Inorg. Chem. Radiochem., 1968, 10, 247–422 CrossRef.
  63. A. Singh, P. Yadav, S. Singh, P. Kumar, S. Srikrishna and V. P. Singh, J. Mater. Chem. C, 2023, 11, 13056–13066 RSC.
  64. M. J. Frisch, G. W. Trucks, H. B. Schlegel, G. E. Scuseria, M. A. Robb Jr. J. R. Cheeseman, J. A. Montgomery, T. Vreven, K. N. Kudin, J. C. Burant, J. M. Millam, S. S. Iyengar, J. Tomasi, V. Barone, B. Mennucci, M. Cossi, G. Scalmani, N. Rega, G. A. Petersson, H. Nakatsuji, M. Hada, M. Ehara, K. Toyota, R. Fukuda, J. Hasegawa, M. Ishida, T. Nakajima, Y. Honda, O. Kitao, H. Nakai, M. Klene, X. Li, J. E. Knox, H. P. Hratchian, J. B. Cross, C. Adamo, J. Jaramillo, R. Gomperts, R. E. Stratmann, O. Yazyev, A. J. Austin, R. Cammi, C. Pomelli, J. W. Ochterski, P. Y. Ayala, K. Morokuma, G. A. Voth, P. Salvador, J. J. Dannenberg, V. G. Zakrzewski, S. Dapprich, A. D. Daniels, M. C. Strain, O. Farkas, D. K. Malick, A. D. Rabuck, K. Raghavachari, J. B. Foresman, J. V. Ortiz, Q. Cui, A. G. Baboul, S. Clifford, J. Cioslowski, B. B Stefanov, G. Liu, A. Liashenko, P. Piskorz, I. Komaromi, R. L. Martin, D. J. Fox, T. Keith, M. . A. Al-Laham, C. Y. Peng, A. Nanayakkara, M. Challacombe, P. M. W. Gill, B. Johnson, W. Chen, M. W. Wong, C. Gonzalez and J. A. Pople, Gaussian 03, Gaussian, Inc., Pittsburgh, PA, 2003 Search PubMed.
  65. C. Adamo and V. Barone, J. Chem. Phys., 1999, 110, 6158–6170 CrossRef CAS.
  66. J. P. Perdew, K. Burke and M. Ernzerhof, Phys. Rev. Lett., 1997, 78, 1396 CrossRef CAS.
  67. K. L. Schuchardt, B. T. Didier, T. Elsethagen, L. Sun, V. Gurumoorthi, J. Chase, J. Li and T. L. Windus, J. Chem. Inf. Model., 2007, 47, 1045–1052 CrossRef CAS PubMed.
  68. V. Kumar and H. Singh, Int. J. Res. Anal. Rev., 2017, 4, 89–95 Search PubMed.
  69. P. Nemykin and V. N. Basu, VMOdes Program, 2001 Search PubMed.
  70. M. Cossi, N. Rega, G. Scalmani and V. Barone, J. Comput. Chem., 2003, 24, 669–681 CrossRef CAS PubMed.
  71. O. V. Dolomanov, L. J. Bourhis, R. J. Gildea, J. A. K. Howard and H. Puschmann, J. Appl. Crystallogr., 2009, 42, 339–341 CrossRef CAS.
  72. G. M. Sheldricka, Acta Crystallogr., Sect. A, 2015, 71, 3–8 CrossRef PubMed.
  73. CCDC 2415220: Experimental Crystal Structure Determination, 2026,  DOI:10.5517/ccdc.csd.cc2m27b9.

Footnote

Equal contribution.

This journal is © The Royal Society of Chemistry 2026
Click here to see how this site uses Cookies. View our privacy policy here.